ERBB2 and breast cancer: Although in univariate analysis, LMR is a prognostic factor for DFS in HR-positive (p = 0.048), HR-negative (0.054), and HER2-negative (p = 0.007) BC patients, it is only an independent prognostic factor for DFS in HER2-negative BC patients (LMR, P = 0.022).